NeoAdjuvant Equity and Outcomes Research Matching Grants

Breast Cancer Canada has joined forces with AstraZeneca Canada to offer two collaborative grants focused on advancing research in new concepts to improve the equity of uptake, experience and outcomes from neo-adjuvant therapy (NACT) in early-stage breast cancer. The new partnership was been formed to drive progress in care for early-stage breast cancer patients.

The funding is available to Canadian research teams, one from Western Canada and one from Eastern Canada, who are developing novel programs to improve accessible referrals for neoadjuvant therapy in early-stage breast cancer and report on clinical and patient reported outcomes.

Two Program Research Grants available, each grant will include $100,000 in funding.

Email LOI and application to: research@breastcancerprogress.ca